New open access chemogenomic database

7 February 2010

The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) recently launched a new online database of genomic-based drug and small molecule information. This open access database, ChEMBLdb, is intended as a resource for researchers aiming to develop potential new therapeutics based on genomic data. It includes records of more than half a million small molecule compounds and their effects on biological systems. ChEMBL team leader Dr John Overington commented: "We hope ChEMBLdb will assist the translation of genomic-based insights into innovative drug therapies" (see press release)

Unusually, this resource was originally a commercial database but was purchased with a £4.7 million Strategic Award from the Wellcome Trust; their director of science funding Alan Schafer said that the move “should have the greatest impact on researchers in academia and in small companies on limited budgets”.

More from us

Genomics and policy news